| Parameter | Details |
|---|---|
| Brand Name | Cafoli Lifecare |
| Industry / Category | Pharmaceutical Products / Healthcare Distribution |
| Founded Year | 2024 |
| Franchise Started | Not specified |
| Total Franchise Outlets | 1–10 |
| Estimated Investment | INR 10,000 – 50,000 (as indicated) |
| Franchise Fee | Not specified |
| Royalty Fee | Not specified |
| Space Requirement | 100 – 200 sq. ft. |
| Staff Requirement | Small team or owner-operated |
| Expected Payback Period | 10–11 months |
Cafoli Lifecare is a pharmaceutical franchise business focused on distributing a wide range of medicinal products across multiple therapeutic categories. The company operates in the healthcare products segment, supplying formulations such as tablets, capsules, syrups, and other treatments to medical and retail channels.
The franchise model is designed for entrepreneurs who want to operate in pharma distribution by marketing and supplying branded products within a defined territory.
The business follows a product distribution model within the pharmaceutical sector.
Operational workflow typically includes:
The model depends on building local networks and maintaining consistent supply to clients.
The company offers a broad pharmaceutical product portfolio covering multiple treatment segments.
General medicines: Tablets, capsules, and syrups
This diversified range allows franchise partners to serve varied healthcare demands.
The Cafoli Lifecare franchise operates on a territory-based pharmaceutical distribution system.
The model emphasizes local market coverage with structured support from the parent company.
The investment requirement is positioned at a relatively low entry level compared to many healthcare businesses.
The estimated investment range is between INR 10,000 and 50,000, depending on the scale of operations and inventory requirements.
The business requires minimal physical infrastructure.
This low space requirement makes the model suitable for small-scale setups.
Support systems are designed to help franchise partners operate effectively in the pharmaceutical sector.
These resources help franchisees build and maintain their distribution network.
Revenue is generated through the sale and distribution of pharmaceutical products.
The expected payback period is estimated at 10–11 months, depending on sales performance and operational efficiency.
Cafoli Lifecare was established in 2024 and operates as a developing pharmaceutical franchise network.
The brand is in an early expansion phase, focusing on increasing its distribution footprint through franchise partnerships across different regions.
The estimated investment ranges from INR 10,000 to 50,000, covering inventory, setup, and operational costs.
The business operates by distributing pharmaceutical products to healthcare providers and retailers, generating revenue through product sales.
A compact space of 100 to 200 square feet is sufficient for storage and basic operations.
The expected payback period is approximately 10 to 11 months, depending on sales volume and market conditions.
Interested investors can apply by contacting the company’s franchise team to initiate onboarding and territory allocation.